ConMed Corp. (NYSE: CNMD), a surgical-device maker founded in the Utica area, recently announced that its board of directors has declared a quarterly cash dividend of 20 cents a share for the fourth quarter. The dividend is payable on Jan. 5 to all shareholders of record as of Dec. 15. ConMed manufactures surgical devices and […]
ConMed Corp. (NYSE: CNMD), a surgical-device maker founded in the Utica area, recently announced that its board of directors has declared a quarterly cash dividend of 20 cents a share for the fourth quarter.
The dividend is payable on Jan. 5 to all shareholders of record as of Dec. 15.
ConMed manufactures surgical devices and equipment for minimally invasive procedures. The company’s products are used by surgeons and physicians in specialties that include orthopedics, general surgery, gynecology, neurosurgery, thoracic surgery, and gastroenterology.
ConMed in late October reported sales of nearly $249 million in the third quarter, up nearly 5 percent from the year-prior quarter. Given the continued uncertainty related to the global pandemic and the impact on hospitals, the company says it is now targeting the lower end of its previously issued full-year 2021 revenue guidance of $1.015 billion to $1.035 billion. ConMed now expects to produce net earnings per share in the range of $3.18 to $3.23 for 2021, compared to its prior range of $3.15 to $3.25.
ConMed, which was headquartered in the Utica area for 50-plus years, at the beginning of 2021 designated Largo, Florida (the Tampa Bay area) as its corporate headquarters. Its Utica–area facility is located at 525 French Road in New Hartford, where the company continues to maintain its manufacturing, finance, human resources, legal, and other corporate functions. The Florida office houses its CEO and other key executives.
Post
Share
Tweet
Print
Email
Get our email updates
Stay up-to-date on the companies, people and issues that impact businesses in Syracuse, Central New York and beyond.
